Stay updated with breaking news from Oratorium Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HeparDx is an emerging NASH/MASH and liver fibrosis blood test designed to diagnose patients earlier and monitor disease progression The data presentations add...
XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering December 21, 2020 17:00 ET | Source: XOMA Corporation XOMA Corporation Emeryville, California, UNITED STATES EMERYVILLE, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced the closing of its previously announced underwritten registered public offering of 984,000 shares, which includes the underwriters option to purchase additional 104,000 shares of its 8.625% Series A Cumulative Perpetual Preferr...
EMERYVILLE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ:XOMA) ("XOMA" or the "Company") today announced the pricing of its underwritten registered public offering of 880,000 shares of 8.625%
EMERYVILLE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ:XOMA) ("XOMA" or the "Company") today announced it has commenced an underwritten registered public offering of shares of its Series A